View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Bortezomib 1.3 / Daratumumab 16 / Dexamethasone (20/20) - Daratumumab 16 maintenance, Multiple Myeloma, Cycle 9+
Protocol-ID: 820 V1.1 (Mini), BORT1,3/DRTM16/DEXA(20/20) - DRTM16 maint., MM, C9+Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
Links
- Daratumumab: Risiko der Reaktivierung von Hepatitis B [BfARM Risikoinf. Rote Hand etc.]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 20.03.2020